Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 045351/0787 | |
| Pages: | 4 |
| | Recorded: | 03/26/2018 | | |
Attorney Dkt #: | IDP-49-USD |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
07/17/2018
|
Application #:
|
15702281
|
Filing Dt:
|
09/12/2017
|
Publication #:
|
|
Pub Dt:
|
01/04/2018
| | | | |
Title:
|
CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST
|
|
Assignee
|
|
|
GEWERBESTRASSE 16 |
ALLSCHWIL, SWITZERLAND CH-4123 |
|
Correspondence name and address
|
|
HOXIE & ASSOCIATES LLC
|
|
75 MAIN STREET
|
|
SUITE 203
|
|
MILLBURN, NJ 07041
|
Search Results as of:
05/30/2024 08:07 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|